Hyperhomocysteinaemia and upper extremity deep venous thrombosis: A case report

Aviation Space and Environmental Medicine

Volumn 70, Issue 7, 1999, Pages 701-704

  Cable, Gordon G ^a  

^a Royal Australian Air Force   (Australia)

Author keywords

Thrombosis homocysteine aviation

Indexed keywords

HEPARIN; HOMOCYSTEINE; UROKINASE; WARFARIN;

ADULT; AIRPLANE CREW; ARTICLE; AVIATION; AXILLARY VEIN; BALLOON CATHETER; BLOOD CLOTTING; CASE REPORT; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FLIGHT; HUMAN; HYPERHOMOCYSTEINEMIA; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; RISK FACTOR; SUBCLAVIAN VEIN;

ADULT; AEROSPACE MEDICINE; AXILLARY VEIN; CAUSALITY; DEHYDRATION; DISABILITY EVALUATION; EXERTION; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MILITARY PERSONNEL; OCCUPATIONAL DISEASES; RECURRENCE; SOUTH AUSTRALIA; SUBCLAVIAN VEIN; VENOUS THROMBOSIS;

EID: 0033004747     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Steinhauser RP, Stewart JC. Deep venous thrombosis in the military pilot. Aviat Space Environ Med 1989; 60:1096-8.
2. Viera AJ. Primary upper-extremity deep venous thrombosis. Mil Med 1997; 162:829-31.
3. Hughes MJ, D'Agostino JC. Upper extremity deep venous thrombosis: a case report and review of current diagnostic/therapeutic modalities. Am J Emerg Med 1994; 12(6):631-5.
4. Bolgiano EB, et al. Deep venous thrombosis of the upper extremity: diagnosis and treatment. J Emerg Med 1990; 8:85-91.
5. Emonson DL. Activated protein C resistance as a "new" cause of deep venous thrombosis in aviators. Aviat Space Environ Med 1997; 68:606-8.
6. Eikelboom JW, Baker RI. Venous thrombosis and hyperhomocysteinaemia. Med J Aust 1998; 169:313-5.
7. Wilcken DEL. Homocysteine and vascular disease. Med J Aust 1998; 168:431-2.
8. Stephens MB. Deep venous thrombosis of the upper extremity. Am Fam Phys 1997; 55(2):533-9.
9. Hurlbert SN, Rutherford RB. Primary subclavian-axillary vein thrombosis. Ann Vase Surg 1995; 9(2):917-23.
10. Decker DM, Philbrick JT, Walker FB. Axillary and subclavian venous thrombosis prognosis and treatment. Arch Int Med 1991; 151:1934-43.
11. Adelman MA, et al. A multidisciplinary approach to the treatment of Paget-Schroetter syndrome. Ann Vase Surg 1997; ll(2):149-54.
12. Grassi CJ, Bettmann MA. Effort thrombosis: role of interventional therapy. Cardiovasc Intervent Radiol 1990; 13(5):317-22.
13. D'Angelo A, Seihub J. Homocysteine and thrombotic disease. Blood 1997; 90:1-11.
14. Florell SR, Rodgers GM. Inherited thrombotic disorders: an update. Am J Hematol 1997; 54:53-60.
15. Selhub J, D'Angelo A. Hyperhomocysteinaemia and thrombosis: acquired conditions. Thromb Haemost 1997; 78(1):527-31.
16. Boers GHJ. The case for mild hyperhomocysteinaemia as a risk factor. J Inherit Metab Dis 1997; 20:301-6.
17. Boers GHJ. Hyperhomocysteinaemia as a risk factor for arterial and venous disease. A review of evidence and relevance. Thromb Haemost 1997; 78(1)520-2.
18. Nvgard O, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337(4):230-6.
19. Rosenberg LE. Inherited disorders of amino acid metabolism and storage. In: K. Isselbacher, et al., ed. Harrison's principles of internal medicine. New York: McGraw-Hill, Inc., 1994.
20. D'Angelo A, et al. Hyperhomocysteinaemia and venous thromboembolic disease. Haematologica 1997; 82:211-9.
21. Ubbink JB. The role of vitamins in the pathogenesis and treatment of hyperhomocysteinaemia. J Inherit Metab Dis 1997; 20:316-25.
22. Glaister DH. The effects of long duration acceleration. In: Ernsting J, ed. Aviation medicine. London: Butterworths, 1988.